SCYNEXIS, Inc.
Support and Resistance Levels
Past performance
News About SCYX
All events for SCYX
All deals for SCYX
Financial Ratios
Financial Statements
SCYX vs Sector & Peers
About SCYNEXIS, Inc.
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ. Website scynexis.com
Headquarters Jersey City, NJ, US